Nova Biomedical is a global leader in in vitro diagnostic instrumentation and analytical solutions, dedicated to advancing patient care and accelerating scientific discovery across the bioprocessing, clinical, veterinary, and food and beverage industries. Headquartered in Waltham, Massachusetts, with manufacturing facilities in Massachusetts, Maine, the United Kingdom, and Taiwan, Nova Biomedical has built a reputation over decades as a company that puts innovation and customer success at the center of everything it does. As the largest privately held IVD company in the United States, Nova Biomedical invests significantly in research and development year after year, maintaining a strong pipeline of breakthrough technologies that continue to raise the bar for performance, accuracy, and workflow efficiency. With direct sales and service organizations in 16 countries and distribution partnerships extending to over 100 countries worldwide, the company's global reach is matched by a commitment to local responsiveness and technical support. In 2025, Nova Biomedical and Advanced Instruments merged, uniting two innovation-driven organizations to deliver even greater value to customers across biopharma, clinical diagnostics, veterinary medicine, and food and beverage quality testing. Whether your lab is in a hospital critical care unit, a biomanufacturing facility, a veterinary clinic, or a food production plant, Nova Biomedical has the instruments, consumables, and expertise to help you achieve dependable results every time.